Syn­log­ic reach­es end of the road for syn­thet­ic bi­ol­o­gy quest af­ter piv­otal da­ta dis­ap­point

Syn­log­ic is clos­ing out its 10-year quest in har­ness­ing syn­thet­ic bi­ol­o­gy to cre­ate new ther­a­pies af­ter de­cid­ing that its lead pro­gram is un­like­ly to suc­ceed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER